Hydroxychloroquine in Covid-19: an open-label, randomized, controlled trial (medrxiv.org)

TLDR: Some alleviation of symptom severity in patients not receiving antivirals, overall no real outcome benefit, way more adverse effects.

Not a slam-dunk in either direction.